Author: Ahn, Jin Young; Sohn, Yujin; Lee, Su Hwan; Cho, Yunsuk; Hyun, Jong Hoon; Baek, Yae Jee; Jeong, Su Jin; Kim, Jung Ho; Ku, Nam Su; Yeom, Joon-Sup; Roh, Juhye; Ahn, Mi Young; Chin, Bum Sik; Kim, Young Sam; Lee, Hyukmin; Yong, Dongeun; Kim, Hyun Ok; Kim, Sinyoung; Choi, Jun Yong
Title: Use of Convalescent Plasma Therapy in Two COVID-19 Patients with Acute Respiratory Distress Syndrome in Korea Document date: 2020_4_6
ID: 1uwir5b8_12
Snippet: The study of the therapeutic benefits of plasma transfusion of a cured person from infectious diseases began in the 20th century. 2 As new antibiotics, antiviral agents, and vaccines are developed, administration of convalescent plasma is not a common treatment, but it can be still an important treatment in the absence of specific treatment of new infectious diseases. 3 Over the decades, convalescent plasma has proved its effectiveness as a poten.....
Document: The study of the therapeutic benefits of plasma transfusion of a cured person from infectious diseases began in the 20th century. 2 As new antibiotics, antiviral agents, and vaccines are developed, administration of convalescent plasma is not a common treatment, but it can be still an important treatment in the absence of specific treatment of new infectious diseases. 3 Over the decades, convalescent plasma has proved its effectiveness as a potential treatment in patients with MERS-CoV, 4 H1N1 5 and H5N1 avian flu, 5 and SARS-CoV. 6 A systemic review and meta-analysis to evaluate the clinical effects of convalescent plasma shows a statistically significant reduction of mortality. 1 In this context, convalescent plasma can be a promising treatment option for severe COVID-19 patients.
Search related documents:
Co phrase search for related documents- antiviral agent and common treatment: 1, 2
- antiviral agent and convalescent plasma: 1, 2, 3, 4
- antiviral agent and important treatment: 1, 2
- antiviral agent and infectious disease: 1, 2, 3, 4, 5, 6, 7, 8
- antiviral agent and meta analysis: 1, 2, 3, 4, 5, 6
- antiviral agent and new antibiotic: 1
- antiviral agent and potential treatment: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- avian flu and common treatment: 1
- avian flu and convalescent plasma: 1
- avian flu and infectious disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
- avian flu and new infectious disease: 1
- clinical effect and common treatment: 1, 2, 3, 4, 5, 6
- clinical effect and convalescent plasma: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- clinical effect and convalescent plasma administration: 1, 2, 3
- clinical effect and convalescent plasma clinical effect: 1, 2, 3, 4, 5, 6
- clinical effect and important treatment: 1, 2, 3, 4, 5, 6, 7, 8
- clinical effect and infectious disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
- clinical effect and meta analysis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- clinical effect and plasma transfusion: 1, 2, 3
Co phrase search for related documents, hyperlinks ordered by date